Cargando…

Emerging targets in pancreatic cancer: epithelial–mesenchymal transition and cancer stem cells

Pancreatic ductal adenocarcinoma is one of the most aggressive solid malignancies and is characterized by poor response to current therapy and a dismal survival rate. Recent insights regarding the role of cancer stem cells (CSCs) and epithelial–mesenchymal transition (EMT) in tumorigenesis have brou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castellanos, Jason A, Merchant, Nipun B, Nagathihalli, Nagaraj S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775701/ https://www.ncbi.nlm.nih.gov/pubmed/24049451 http://dx.doi.org/10.2147/OTT.S34670

Ejemplares similares

Emerging Role of CREB in Epithelial to Mesenchymal Plasticity of Pancreatic Cancer
por: Mehra, Siddharth, et al.
Publicado: (2022)

Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response
por: Walsh, Alex J., et al.
Publicado: (2016)

Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells
por: Nagathihalli, Nagaraj S., et al.
Publicado: (2016)

Src kinase inhibition restores E-cadherin expression in dasatinib-sensitive pancreatic cancer cells
por: Dosch, Austin R., et al.
Publicado: (2019)

Adiponectin receptor agonists inhibit leptin induced pSTAT3 and in vivo pancreatic tumor growth
por: Messaggio, Fanuel, et al.
Publicado: (2017)

Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming metabolic pathways
por: Kesh, Kousik, et al.
Publicado: (2020)

Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress
por: Mehra, Siddharth, et al.
Publicado: (2021)

New mechanistic insights into modifiable risk factors that promote pancreatic cancer
por: Srinivasan, Supriya, et al.
Publicado: (2019)

Regulators of epithelial mesenchymal transition in pancreatic cancer
por: Hamada, Shin, et al.
Publicado: (2012)

Targeting epithelial-mesenchymal transition and cancer stem cells for chemoresistant ovarian cancer
por: Deng, Junli, et al.
Publicado: (2016)

Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition
por: Espinoza, Ingrid, et al.
Publicado: (2013)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2018)

Conversion of epithelial-to-mesenchymal transition to mesenchymal-to-epithelial transition is mediated by oxygen concentration in pancreatic cancer cells
por: Chen, Shuo, et al.
Publicado: (2022)

Contribution of Epithelial-Mesenchymal Transition to Pancreatic Cancer Progression
por: Krantz, Seth B., et al.
Publicado: (2010)

The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer
por: Zhou, Pingting, et al.
Publicado: (2017)

Hedgehog Signaling Regulates Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem-Like Cells
por: Wang, Feng, et al.
Publicado: (2016)

MicroRNA-30b targets Snail to impede epithelial-mesenchymal transition in pancreatic cancer stem cells
por: Xiong, Yicheng, et al.
Publicado: (2018)

Remodeling of Stromal Immune Microenvironment by Urolithin A Improves Survival with Immune Checkpoint Blockade in Pancreatic Cancer
por: Mehra, Siddharth, et al.
Publicado: (2023)

Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer
por: Karamitopoulou, Eva
Publicado: (2013)

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
por: Elaskalani, Omar, et al.
Publicado: (2017)

Epithelial-Mesenchymal Transition in Pancreatic Cancer: A Review
por: Wang, Shuai, et al.
Publicado: (2017)

SET contributes to the epithelial-mesenchymal transition of pancreatic cancer
por: Mody, Hardik R., et al.
Publicado: (2017)

MiR-200a inhibits epithelial-mesenchymal transition of pancreatic cancer stem cell
por: Lu, Yuhua, et al.
Publicado: (2014)

Truncated O‐glycans promote epithelial‐to‐mesenchymal transition and stemness properties of pancreatic cancer cells
por: Thomas, Divya, et al.
Publicado: (2019)

The Emerging Role of Exosomes in Epithelial–Mesenchymal-Transition in Cancer
por: Vella, Laura Jayne
Publicado: (2014)

Emerging role of epithelial-mesenchymal transition in hepatic cancer
por: Yoshida, Go J.
Publicado: (2016)

Targeting Epithelial Mesenchymal Plasticity in Pancreatic Cancer: A Compendium of Preclinical Discovery in a Heterogeneous Disease
por: Monkman, James H., et al.
Publicado: (2019)

Epithelial-Mesenchymal Transition and Its Regulation Mechanisms in Pancreatic Cancer
por: Luu, Tuan
Publicado: (2021)

Epithelial-mesenchymal transition, cancer stem cells and treatment resistance
por: Dave, Bhuvanesh, et al.
Publicado: (2012)

Links between cancer stem cells and epithelial–mesenchymal transition
por: Wang, Sha-sha, et al.
Publicado: (2015)

Epithelial–mesenchymal transition in cancer stem cells: Therapeutic implications
por: Varun, BR, et al.
Publicado: (2023)

Targeting Cancer-Related Inflammation: Chinese Herbal Medicine Inhibits Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
por: Zhang, Juan, et al.
Publicado: (2013)

Epithelial-Mesenchymal Transition in Pancreatic Carcinoma
por: Maier, Harald J., et al.
Publicado: (2010)

Epithelial-to-Mesenchymal Transition in Pancreatic Adenocarcinoma
por: Cano, Carla, et al.
Publicado: (2010)

Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation
por: Polireddy, Kishore, et al.
Publicado: (2016)

Emerging Concepts of Hybrid Epithelial-to-Mesenchymal Transition in Cancer Progression
por: Sinha, Dona, et al.
Publicado: (2020)

DAXX inhibits cancer stemness and epithelial–mesenchymal transition in gastric cancer
por: Wu, Chaofan, et al.
Publicado: (2020)

Emodin reverses resistance to gemcitabine in pancreatic cancer by suppressing stemness through regulation of the epithelial‑mesenchymal transition
por: Wei, Weitian, et al.
Publicado: (2022)

Targeting the Epithelial-to-Mesenchymal Transition in Cancer Stem Cells for a Better Clinical Outcome of Glioma
por: Lu, Yu-bao, et al.
Publicado: (2020)

Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers
por: Song, Yizuo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bs9fgdbq0o44r5jnc66hdnmp5s